Show simple item record

dc.contributor.advisorMaitra, Radhashree
dc.contributor.authorSapir, Tzuriel M.
dc.date.accessioned2022-05-23T15:56:49Z
dc.date.available2022-05-23T15:56:49Z
dc.date.issued2022-05
dc.identifier.citationSapir, T.M. (2022, May). Protein Arginine Methyltransferase 5 May Interact with KRAS through PPP2CA. Undergraduate honors thesis, Yeshiva University.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12202/8202
dc.descriptionUndergraduate honors thesis / Opt-outen_US
dc.description.abstractDespite decades of research and its status as one of the most mutated oncoproteins in colorectal cancer (CRC), targeted therapies are yet to have been developed for the KRAS protein. To this extent, a previous study by our group found that, in CRC, KRAS may interact with another oncoprotein, called Protein Arginine Methyltransferase 5 (PRMT5). PRMT5 is an epigenetic regulator in multiple cellular processes and is overexpressed in 75% of CRC patient tumor samples while being negatively correlated with CRC patient survival. Therefore, our previous findings suggest that it might be possible to target the prominent oncoprotein KRAS through its potential interactions with the oncoprotein PRMT5. Here, we look more closely at the KRAS-PRMT5 interaction and suggest that PRMT5 may interact with KRAS through PPP2CA. We first show that PRMT5 may interact with KRAS through PPP2CA using the STRING database. We next show that PPP2CA is over expressed in CRC patient datasets. We then show that PPP2CA expression is strongly correlated with PRMT5 and KRAS expression in CRC patient datasets. We next model these protein-protein interactions and show that PPP2CA expression is correlated with patient survival in CRC patient datasets. Finally, we propose a mechanism through which PRMT5 may interact with KRAS by inhibiting PPP2CA.en_US
dc.description.sponsorshipThe Jay and Jeanie Schottenstein Honors Programen_US
dc.language.isoen_USen_US
dc.publisherYeshiva College, Yeshiva Universityen_US
dc.relation.ispartofseriesThe Jay and Jeanie Schottenstein Honors Theses;May 2022
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectoncoproteinsen_US
dc.subjectColorectal Cancer (CRC)en_US
dc.subjectProtein Arginine Methyltransferase 5 (PRMT5)en_US
dc.subjectKRAS proteinen_US
dc.subjectPPP2CAen_US
dc.titleProtein Arginine Methyltransferase 5 May Interact with KRAS through PPP2CAen_US
dc.typeThesisen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States